1. Division of Epidemiology and Prevention, Aichi Cancer Center, Nagoya;
2. Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo;
3. Division of Molecular Science, Tokai University School of Medicine, Isehara;
4. HLA Laboratory, NPO, Kyoto;
5. The 21st Century COE Program, Graduate School of Medicine, University of Tokyo, Tokyo;
6. Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara;
7. International Medical Center of Japan, Tokyo;
8. Japanese Red Cross Nagoya First Hospital, Nagoya; and
9. Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan